Vanguard Group Inc Axogen, Inc. Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,730,401 shares of AXGN stock, worth $49.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,730,401
Previous 2,538,607
7.56%
Holding current value
$49.6 Million
Previous $47 Million
36.92%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding AXGN
# of Institutions
169Shares Held
40.2MCall Options Held
69.1KPut Options Held
0-
First Light Asset Management, LLC Edina, MN4.53MShares$82.3 Million7.55% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$59 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.51MShares$45.6 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.93MShares$35.1 Million0.03% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO1.63MShares$29.5 Million0.36% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $768M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...